Skip to content

Clinical trials

Withdrawn Phase 1 Pancreatic Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pancreatic Neoplasms Phase: Phase 1 Status: Withdrawn Clear all

42 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20081
20101
20112
20123
20144
20152
20163
20181
20193
20201
20214
20224
20235
20243
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Withdrawn42

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center3
Roswell Park Cancer Institute3
City of Hope Medical Center2
National Cancer Institute (NCI)2
Abramson Cancer Center at Penn Medicine1
Beijing Kejing Biotechnology Co., Ltd.1
BioXcel Therapeutics Inc1
Case Comprehensive Cancer Center1
Cedars-Sinai Medical Center1
Conjupro Biotherapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pancreatic Neoplasms42
Breast Neoplasms7
Colorectal Neoplasms6
Ovarian Neoplasms5
Stomach Neoplasms5
Colonic Neoplasms3
Neoplasm Metastasis3
Neoplasms3
Cholangiocarcinoma2
Esophageal Neoplasms2

Trials

Showing 1 to 25 of 42. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.